Sharp spike in pharma, healthcare funding in April 2024, touches $332 mn

API Holdings secured the biggest deal ($216 million), followed by La Renon ( $70 million) and Biodeal Pharmaceuticals ($13.2 million).

Funding was raised by 291 per cent for the sector in April 2024, 1045 per cent higher than the same month last year ($29 million) , accounting for $332 million, over 15 rounds in total.

As per the data presented by Tracxn.com, API Holdings secured the biggest deal by raising $216 million in healthcare, healthtech and life sciences. It was followed by La Renon ( $70 million) and Biodeal Pharmaceuticals ($13.2 million).

In terms of stage-wise funding, the majority of it occurred in the final stages (86.2 per cent), followed by 12.2 per cent  in the early-stage and 1.5 per cent in the seed-stage. 

This is the highest observed number since November 2023 ($500 million)